Development of Medicines for Rare Pediatric Diseases
To date, approximately 7000 rare diseases exist, affecting between 6% and 8% of the global population and >30 million people in the European Union [...]
Saved in:
Main Authors: | Danilo Marimpietri (Author), Guendalina Zuccari (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics
by: Guendalina Zuccari, et al.
Published: (2022) -
Pyrazole-Enriched Cationic Nanoparticles Induced Early- and Late-Stage Apoptosis in Neuroblastoma Cells at Sub-Micromolar Concentrations
by: Guendalina Zuccari, et al.
Published: (2023) -
AmBisome<sup>®</sup> Formulations for Pediatrics: Stability, Cytotoxicity, and Cost-Effectiveness Studies
by: Guendalina Zuccari, et al.
Published: (2024) -
Increased Water-Solubility and Maintained Antioxidant Power of Resveratrol by Its Encapsulation in Vitamin E TPGS Micelles: A Potential Nutritional Supplement for Chronic Liver Disease
by: Guendalina Zuccari, et al.
Published: (2021) -
Preparation and Characterization of Amorphous Solid Dispersions for the Solubilization of Fenretinide
by: Guendalina Zuccari, et al.
Published: (2023)